Artemis Medicare Halts Share Trading April 1 for Q4 Results

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Artemis Medicare Halts Share Trading April 1 for Q4 Results
Overview

Artemis Medicare Services Ltd. will close its trading window for designated persons and their relatives starting April 1, 2026. This action complies with SEBI regulations to prevent insider trading before the company announces its financial results for the period ending March 31, 2026. The window will reopen 48 hours after the results are officially announced.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Artemis Medicare Halts Share Trading Ahead of Q4 Results

Artemis Medicare Services Ltd. announced it will close its trading window for designated employees and their immediate relatives starting April 1, 2026. This measure is a regulatory requirement to prevent insider trading as the company prepares to announce its financial results for the fiscal year and quarter ending March 31, 2026. The window is scheduled to reopen 48 hours after the official release of these results.

Purpose of Trading Windows

Trading window closures are a standard SEBI compliance measure. They ensure fairness and transparency by preventing individuals with access to non-public, price-sensitive information from trading securities before the public is informed. This practice helps maintain investor confidence by avoiding any perception of unfair advantage for company insiders.

Company Context and Recent Performance

Artemis Medicare Services Ltd. operates a network of multi-specialty hospitals in India, with its main facility in Gurugram. The company recently reported its third-quarter results for FY26, showing revenue of approximately ₹272.35 crore and a net profit of about ₹22.23 crore. SEBI has strengthened insider trading regulations, expanding trading window closures to include immediate relatives of designated persons, reflecting a broader push for stricter compliance in the securities market.

Trading Restrictions

During the closure period, designated employees and their immediate relatives are prohibited from buying or selling Artemis Medicare Services Ltd. shares. This restriction is in place to protect the integrity of the upcoming financial results announcement.

Potential Risks

While the trading window closure is a procedural event, the main risk for investors lies in the upcoming Q4 FY26 financial results themselves. Any negative surprises or significant deviations from expectations could impact the company's stock. Additionally, non-compliance with SEBI's insider trading norms carries its own set of regulatory risks.

Peer Practices

Major healthcare companies like Apollo Hospitals Enterprise Ltd. and Fortis Healthcare Ltd. also follow similar trading window closure policies, highlighting the importance of transparency and fair trading practices in the highly regulated healthcare sector.

What to Monitor Next

Investors should look for the official announcement date of Artemis Medicare Services Ltd.'s Q4 and full-year FY26 financial results. The timing of the trading window's reopening, 48 hours post-announcement, will also be a key indicator. Following the release, analysts will examine the financial performance and its potential implications for the company's future outlook.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.